Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior

Journal of Immunology

Volumn 182, Issue 5, 2009, Pages 3202-3212

  O'Connor, Jason C ^a   Lawson, Marcus A ^a   André, Caroline ^a   Briley, Eileen M ^c   Szegedi, Sandra S ^a   Lestage, Jacques ^d   Castanon, Nathalie ^d   Herkenham, Miles ^c   Dantzer, Robert ^a,b   Kelley, Keith W ^a,b  

^a Department of Animal Sciences   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYANTHRANILIC ACID OXYGENASE; BCG VACCINE; GAMMA INTERFERON; KYNURENINE; MESSENGER RNA; OXYGENASE; QUINOLINIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; INDOLEAMINE 2,3 DIOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; GENETIC TRANSCRIPTION; HEREDITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEADY STATE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; COMPARATIVE STUDY; ENZYME INDUCTION; ENZYMOLOGY; GENETICS; IMMUNOLOGY; INFLAMMATION; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; MOTOR ACTIVITY; MOUSE MUTANT; PHYSIOLOGY; TRANSCRIPTION INITIATION; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; BCG VACCINE; CHRONIC DISEASE; DEPRESSION; ENZYME INDUCTION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, KNOCKOUT; MICE, TRANSGENIC; MOTOR ACTIVITY; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 64849115090     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802722     Document Type: Article

References (79)

1. World Health Organization/Stop TB Partnership. 2008. Tuberculosis Facts. World Health Organization, Geneva, Switzerland.
2. Kaufmann, S. H., and A. J. McMichael. 2005. Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat. Med. 11(4 Suppl.): S33-S44.
3. Brewer, T. F. 2000. Preventing tuberculosis with Bacillus Calmette-Guerin vaccine: a meta-analysis of the literature. Clin. Infect. Dis. 31(Suppl 3): S64-S67.
4. Mittrucker, H. W., U. Steinhoff, A. Kohler, M. Krause, D. Lazar, P. Mex, D. Miekley, and S. H. Kaufmann. 2007. Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis. Proc. Natl. Acad. Sci. USA 104: 12434-12439.
5. Egen, J. G., A. G. Rothfuchs, C. G. Feng, N. Winter, A. Sher, and R. N. Germain. 2008. Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. Immunity 28: 271-284.
6. Kaufmann, S. H., C. H. Ladel, and I. E. Flesch. 1995. T cells and cytokines in intracellular bacterial infections: experiences with Mycobacterium bovis BCG. Ciba Found. Symp. 195: 123-132; discussion 132-126.
7. Tsenova, L., A. Bergtold, V. H. Freedman, R. A. Young, and G. Kaplan. 1999. Tumor necrosis factor α is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc. Natl. Acad. Sci. USA 96: 5657-5662.
8. Heldwein, K. A., and M. J. Fenton. 2002. The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect. 4: 937-944.
9. + T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. Infect. Immun. 69: 2666-2674.
10. + T cells recognizing CFP10 are recruited to the lung after Mycobacterium tuberculosis infection. J. Exp. Med. 200: 1479-1489.
11. Mogues, T., M. E. Goodrich, L. Ryan, R. LaCourse, and R. J. North. 2001. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 193: 271-280.
12. + T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect. Immun. 67: 3980-3988.
13. O'Connor, J. C., M. A. Lawson, C. Andre, M. Moreau, J. Lestage, N. Castanon, K. W. Kelley, and R. Dantzer. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol. Psychiatry In press.
14. Moreau, M., J. Lestage, D. Verrier, C. Mormede, K. W. Kelley, R. Dantzer, and N. Castanon. 2005. Bacille Calmette-Guerin inoculation induces chronic activation of peripheral and brain indoleamine 2,3-dioxygenase in mice. J. Infect. Dis. 192: 537-544.
15. Dantzer, R., J. C. O'Connor, G. G. Freund, R. W. Johnson, and K. W. Kelley. 2008. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9: 46-56.
16. Kopnisky, K. L., J. Bao, and Y. W. Lin. 2007. Neurobiology of HIV, psychiatric and substance abuse comorbidity research: workshop report. Brain Behav. Immun. 21: 428-441.
17. Moussavi, S., S. Chatterji, E. Verdes, A. Tandon, V. Patel, and B. Ustun. 2007. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370: 851-858.
18. Fujigaki, S., K. Saito, M. Takemura, N. Maekawa, Y. Yamada, H. Wada, and M. Seishima. 2002. L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase. Infect. Immun. 70: 779-786.
19. MacKenzie, C. R., K. Heseler, A. Muller, and W. Daubener. 2007. Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines. Curr. Drug Metab. 8: 237-244.
20. Munn, D. H., M. Zhou, J. T. Attwood, I. Bondarev, S. J. Conway, B. Marshall, C. Brown, and A. L. Mellor. 1998. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281: 1191-1193.
21. Mellor, A. L., J. Sivakumar, P. Chandler, K. Smith, H. Molina, D. Mao, and D. H. Munn. 2001. Prevention of T cell-driven complement activation and in-flammation by tryptophan catabolism during pregnancy. Nat. Immunol. 2: 64-68.
22. Frumento, G., R. Rotondo, M. Tonetti, G. Damonte, U. Benatti, and G. B. Ferrara. 2002. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med. 196: 459-468.
23. Munn, D. H., E. Shafizadeh, J. T. Attwood, I. Bondarev, A. Pashine, and A. L. Mellor. 1999. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189: 1363-1372.
24. Terness, P., T. M. Bauer, L. Rose, C. Dufter, A. Watzlik, H. Simon, and G. Opelz. 2002. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196: 447-457.
25. Munn, D. H., M. D. Sharma, J. R. Lee, K. G. Jhaver, T. S. Johnson, D. B. Keskin, B. Marshall, P. Chandler, S. J. Antonia, R. Burgess, et al. 2002. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297: 1867-1870.
26. Munn, D. H., and A. L. Mellor. 2007. Indoleamine 2,3-dioxygenase and tumorinduced tolerance. J. Clin. Invest. 117: 1147-1154.
27. Sharma, M. D., B. Baban, P. Chandler, D. Y. Hou, N. Singh, H. Yagita, M. Azuma, B. R. Blazar, A. L. Mellor, and D. H. Munn. 2007. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J. Clin. Invest. 117: 2570-2582.
28. Fuchs, D., A. A. Moller, G. Reibnegger, E. Stockle, E. R. Werner, and H. Wachter. 1990. Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. J. Acquir. Immune Defic. Syndr. 3: 873-876.
29. Schrocksnadel, K., B. Wirleitner, C. Winkler, and D. Fuchs. 2006. Monitoring tryptophan metabolism in chronic immune activation. Clin. Chim. Acta 364: 82-90.
30. Schroecksnadel, K., S. Kaser, M. Ledochowski, G. Neurauter, E. Mur, M. Herold, and D. Fuchs. 2003. Increased degradation of tryptophan in blood of patients with rheumatoid arthritis. J. Rheumatol. 30: 1935-1939.
31. Widner, B., N. Sepp, E. Kowald, U. Ortner, B. Wirleitner, P. Fritsch, G. Baier-Bitterlich, and D. Fuchs. 2000. Enhanced tryptophan degradation in systemic lupus erythematosus. Immunobiology 201: 621-630.
32. Wirleitner, B., V. Rudzite, G. Neurauter, C. Murr, U. Kalnins, A. Erglis, K. Trusinskis, and D. Fuchs. 2003. Immune activation and degradation of tryptophan in coronary heart disease. Eur. J. Clin. Invest. 33: 550-554.
33. Smith, R. S. 1991. The macrophage theory of depression. Med. Hypotheses 35: 298-306.
34. Maes, M., R. Smith, and S. Scharpe. 1995. The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 20: 111-116.
35. Maes, M., R. Verkerk, S. Bonaccorso, W. Ombelet, E. Bosmans, and S. Scharpe. 2002. Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation. Life Sci. 71: 1837-1848.
36. Widner, B., A. Laich, B. Sperner-Unterweger, M. Ledochowski, and D. Fuchs. 2002. Neopterin production, tryptophan degradation, and mental depression - what is the link? Brain Behav. Immun. 16: 590-595.
37. Capuron, L., A. Ravaud, P. J. Neveu, A. H. Miller, M. Maes, and R. Dantzer. 2002. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol. Psychiatry 7: 468-473.
38. Wichers, M. C., G. H. Koek, G. Robaeys, R. Verkerk, S. Scharpe, and M. Maes. 2005. IDO and interferon-α-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol. Psychiatry 10: 538-544.
39. Moreau, M., C. Andre, J. C. O'Connor, S. A. Dumich, J. A. Woods, K. W. Kelley, R. Dantzer, J. Lestage, and N. Castanon. 2008. Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior. Brain Behav. Immun. 22: 1087-1095.
40. Andre, C., J. C. O'Connor, K. W. Kelley, J. Lestage, R. Dantzer, and N. Castanon. 2008. Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administration. J. Neuroimmunol. 200: 90-99.
41. Fujigaki, S., K. Saito, K. Sekikawa, S. Tone, O. Takikawa, H. Fujii, H. Wada, A. Noma, and M. Seishima. 2001. Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-γ-independent mechanism. Eur. J. Immunol. 31: 2313-2318.
42. Schroecksnadel, K., R. Zangerle, R. Bellmann-Weiler, K. Garimorth, G. Weiss, and D. Fuchs. 2007. Indoleamine-2, 3-dioxygenase and other interferon-γ-mediated pathways in patients with human immunodeficiency virus infection. Curr. Drug Metab. 8: 225-236.
43. Kohl, C., and B. Sperner-Unterweger. 2007. IDO and clinical conditions associated with depressive symptoms. Curr. Drug Metab. 8: 283-287.
44. Connor, T. J., N. Starr, J. B. O'Sullivan, and A. Harkin. 2008. Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-γ? Neurosci. Lett. 441: 29-34.
45. + plasmacytoid dendritic cells. Curr. Drug Metab. 8: 209-216.
46. Lestage, J., D. Verrier, K. Palin, and R. Dantzer. 2002. The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain. Behav. Immun. 16: 596-601.
47. Godbout, J. P., M. Moreau, J. Lestage, J. Chen, N. L. Sparkman, J. O'Connor, N. Castanon, K. W. Kelley, R. Dantzer, and R. W. Johnson. 2008. Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system. Neuropsychopharmacology 33: 2341-2351.
48. Kindler, V., A. P. Sappino, G. E. Grau, P. F. Piguet, and P. Vassalli. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56: 731-740.
49. Harrington, L., C. V. Srikanth, R. Antony, S. J. Rhee, A. L. Mellor, H. N. Shi, and B. J. Cherayil. 2008. Deficiency of indoleamine 2,3-dioxygenase enhances commensal-induced antibody responses and protects against Citrobacter rodentium-induced colitis. Infect. Immun. 76: 3045-3053.
50. Brandacher, G., R. Margreiter, and D. Fuchs. 2007. Implications of IFN-γ-mediated tryptophan catabolism on solid organ transplantation. Curr. Drug Metab. 8: 273-282.
51. Xu, H., T. B. Oriss, M. Fei, A. C. Henry, B. N. Melgert, L. Chen, A. L. Mellor, D. H. Munn, C. G. Irvin, P. Ray, and A. Ray. 2008. Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation. Proc. Natl. Acad. Sci. USA 105: 6690-6695.
52. Mellor, A. L., and D. H. Munn. 2008. Creating immune privilege: active local suppression that benefits friends, but protects foes. Nat. Rev. 8: 74-80.
53. Heseler, K., K. Spekker, S. K. Schmidt, C. R. MacKenzie, and W. Daubener. 2008. Antimicrobial and immunoregulatory effects mediated by human lung cells: role of IFN-γ-induced tryptophan degradation. FEMS Immunol. Med. Microbiol. 52: 273-281.
54. Hayashi, T., S. P. Rao, K. Takabayashi, J. H. Van Uden, R. S. Kornbluth, S. M. Baird, M. W. Taylor, D. A. Carson, A. Catanzaro, and E. Raz. 2001. Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase. Infect. Immun. 69: 6156-6164.
55. Ball, H. J., A. Sanchez-Perez, S. Weiser, C. J. Austin, F. Astelbauer, J. Miu, J. A. McQuillan, R. Stocker, L. S. Jermiin, and N. H. Hunt. 2007. Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene 396: 203-213.
56. Ball, H. J., H. J. Yuasa, C. J. Austin, S. Weiser, and N. H. Hunt. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway. Int. J. Biochem. Cell Biol. In press.
57. Prendergast, G. C. 2008. Immune escape as a fundamental trait of cancer: focus on IDO. Oncogene 27: 3889-3900.
58. Lob, S., and A. Konigsrainer. 2008. Is IDO a key enzyme bridging the gap between tumor escape and tolerance induction? Langenbecks Arch. Surg. 393: 995-1003.
59. Lob, S., A. Konigsrainer, R. Schafer, H. G. Rammensee, G. Opelz, and P. Terness. 2008. Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells. Blood 111: 2152-2154.
60. Lob, S., A. Konigsrainer, D. Zieker, B. L. Brucher, H. G. Rammensee, G. Opelz, and P. Terness. 2009. IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism. Cancer Immunol. Immunother. 58: 153-157.
61. Hou, D. Y., A. J. Muller, M. D. Sharma, J. DuHadaway, T. Banerjee, M. Johnson, A. L. Mellor, G. C. Prendergast, and D. H. Munn. 2007. Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses. Cancer Res. 67: 792-801.
62. Metz, R., J. B. Duhadaway, U. Kamasani, L. Laury-Kleintop, A. J. Muller, and G. C. Prendergast. 2007. Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res. 67: 7082-7087.
63. Wright, C. E., P. C. Strike, L. Brydon, and A. Steptoe. 2005. Acute inflammation and negative mood: mediation by cytokine activation. Brain Behav. Immun. 19: 345-350.
64. Dunn, A. J., and A. H. Swiergiel. 2005. Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice. Pharmacol. Biochem. Behav. 81: 688-693.
65. Dunn, A. J., A. H. Swiergiel, H. Zhang, and N. Quan. 2006. Reduced ingestion of sweetened milk induced by interleukin-1 and lipopolysaccharide is associated with induction of cyclooxygenase-2 in brain endothelia. Neuroimmunomodulation 13: 96-104.
66. Frenois, F., M. Moreau, J. O'Connor, M. Lawson, C. Micon, J. Lestage, K. W. Kelley, R. Dantzer, and N. Castanon. 2007. Lipopolysaccharide induces delayed FosB/ΔFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 32: 516-531.
67. Husain, M. O., S. P. Dearman, I. B. Chaudhry, N. Rizvi, and W. Waheed. 2008. The relationship between anxiety, depression and illness perception in tuberculosis patients in Pakistan. Clin. Pract. Epidemol. Ment. Health 4: 4.
68. Vega, P., A. Sweetland, J. Acha, H. Castillo, D. Guerra, M. C. Smith Fawzi, and S. Shin. 2004. Psychiatric issues in the management of patients with multidrugresistant tuberculosis. Int. J. Tuberc. Lung Dis. 8: 749-759.
69. Makino, K., K. Satoh, T. Fujiki, and K. Kawaguchi. 1952. Relation of 3-hydroxykynurenine to the Ehrlich diazo reaction of urine in severe tuberculosis. Nature 170: 977-978.
70. Nair, S., W. Maguire, H. Baron, and R. Imbruce. 1976. The effect of cycloserine on pyridoxine-dependent metabolism in tuberculosis. J. Clin. Pharmacol. 16: 439-443.
71. Burudi, E. M., M. C. Marcondes, D. D. Watry, M. Zandonatti, M. A. Taffe, and H. S. Fox. 2002. Regulation of indoleamine 2,3-dioxygenase expression in simian immunodeficiency virus-infected monkey brains. J. Virol. 76: 12233-12241.
72. Robinson, C. M., P. T. Hale, and J. M. Carlin. 2006. NF-κB activation contributes to indoleamine dioxygenase transcriptional synergy induced by IFN-γ and tumor necrosis factor-α. Cytokine 35: 53-61.
73. Robinson, C. M., K. A. Shirey, and J. M. Carlin. 2003. Synergistic transcriptional activation of indoleamine dioxygenase by IFN-γ and tumor necrosis factor-α. J. Interferon Cytokine Res. 23: 413-421.
74. Shi, S., C. Nathan, D. Schnappinger, J. Drenkow, M. Fuortes, E. Block, A. Ding, T. R. Gingeras, G. Schoolnik, S. Akira, et al. 2003. MyD88 primes macrophages for full-scale activation by interferon-γ yet mediates few responses to Mycobacterium tuberculosis. J. Exp. Med. 198: 987-997.
75. +-independent transporter of neutral amino acids in astrocytes. J. Neurosci. 9: 2066-2072.
76. Speciale, C., and R. Schwarcz. 1990. Uptake of kynurenine into rat brain slices. J. Neurochem. 54: 156-163.
77. Turski, W. A., J. B. Gramsbergen, H. Traitler, and R. Schwarcz. 1989. Rat brain slices produce and liberate kynurenic acid upon exposure to L-kynurenine. J. Neurochem. 52: 1629-1636.
78. Guillemin, G. J., G. Smythe, O. Takikawa, and B. J. Brew. 2005. Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia 49: 15-23.
79. Jia, L., K. Schweikart, J. Tomaszewski, J. G. Page, P. E. Noker, S. A. Buhrow, J. M. Reid, M. M. Ames, and D. H. Munn. 2008. Toxicology and pharmacokinetics of 1-methyl-D-tryptophan: absence of toxicity due to saturating absorption. Food Chem. Toxicol. 46: 203-211.